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A B S T R A C T
Purpose: Postictal pulmonary edema (PPE) is almost invariably present in human and animal cases of
sudden unexpected death in epilepsy (SUDEP) coming to autopsy. PPE may be a contributing factor in
SUDEP. The incidence of postictal PPE is unknown. We retrospectively investigated PPE following
generalized tonic clonic seizures (GTCS) in the epilepsy monitoring unit.
Method: Chest X-rays (CXR) following each GTCS were obtained in 24 consecutive patients. Relationship
of CXR abnormality to seizure duration, ictal/postictal oxygen desaturation (SpO2), apnea and presence
of postictal generalized EEG suppression (PGES) was investigated using logistic regression.
Results: Eleven of 24 patients had CXR abnormalities following a GTCS. In these 11 patients, 22 CXR were
obtained and abnormalities were present in 15 CXR. Abnormalities included PPE in 7 patients, of which 2
also had focal inﬁltrates. In 4 patients focal inﬁltrates were present without PPE. There was no signiﬁcant
difference in mean time to CXR (225 min) following GTCS in the abnormal CXR group versus the normal
group of patients (196 min).
Mean preceding seizure duration was longer (p = 0.002) in GTCS with abnormal CXR (259.7 s) versus
GTCS with normal CXR (101.2 s). Odds-ratio for CXR abnormality was 20.46 (p = 0.006) with seizure
duration greater than 100 s versus less than 100 s. On multivariable analysis, only the seizure duration
was a signiﬁcant predictor of CXR abnormality (p = 0.015).
Conclusion: Radiographic abnormalities are not uncommon following GTCS. The presence of CXR
abnormality is signiﬁcantly associated with the duration of the preceding GTCS. Severe, untreated PPE
may be relevant to the pathophysiology of SUDEP.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Postictal pulmonary edema (PPE) may be one factor leading to
sudden unexpected death in epilepsy (SUDEP) [1]. The relevance of
PPE to SUDEP remains controversial and insufﬁciently investigat-
ed. Case reports indicate that PPE occurs in a subset of individuals
following convulsions, and may recur with subsequent convul-
sions and lead to SUDEP [2–7]. In an autopsy study of 74 cases of
SUDEP, 52 had microscopic examinations of the lungs that showed
moderate to marked pulmonary congestion and edema in all 52
cases [8]. In epileptic primates PPE is likely a factor in the* Corresponding author at: Department of Neurology, University of California
Davis, Clinical Neurophysiology, 2315 Stockton Boulevard, Room 5308, Sacramento,
CA 95817, USA. Tel.: +1 916 734 2636; fax: +1 916 703 5005.
E-mail address: mseyal@ucdavis.edu (M. Seyal).
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights repathophysiology of SUDEP [9]. Autopsies of 48 epileptic baboons
that died suddenly were compared with 78 non-epileptic baboons.
Almost all epileptic baboons that died suddenly without apparent
cause had PPE without other pathology and about half had bloody
frothy sputum [9].
Despite these observations, recent reviews of SUDEP patho-
physiology concluded that PPE following seizures is mild,
uncommon and not likely an etiological factor resulting in death
[10–12]. This notion may be based in part on two studies [13,14]. A
retrospective review of 45 patients who had chest radiographs
(CXR) obtained in an emergency department following presumed
generalized tonic clonic seizures (GTCS) demonstrated that only
one had PPE [13]. In CXRs obtained following electroconvulsive
therapy only 1 of 12 patients had radiographic evidence of
subclinical PPE [14].
The incidence of postictal PPE is unknown given that CXRs are
infrequently obtained after GTCS. Given the discrepancy in priorserved.
J.D. Kennedy et al. / Seizure 27 (2015) 19–2420studies regarding the occurrence of PPE, we sought to determine
the incidence and extent of pulmonary abnormalities following
GTCS and evaluate patient and seizure characteristics in patients
undergoing video-EEG telemetry (VET) in the epilepsy monitoring
unit (EMU).
2. Methods
We retrospectively examined CXRs in consecutive patients who
had GTCS while undergoing VET in the University of California,
Davis Medical Center EMU. All patients undergoing VET in this
EMU have concurrent synchronized recording of nasal airﬂow,
abdominal excursions, digital pulse oximetry, end-tidal CO2
(ETCO2), and 3-channel electrocardiogram. Details of the meth-
odology have been previously published [15]. By protocol portable
bedside CXRs are ordered immediately following all GTCS in
patients admitted to the EMU. The practice of obtaining CXR after
GTCS was instituted in the EMU once we became aware of human
autopsy ﬁndings and animal data indicating pulmonary edema in
SUDEP. Antiepileptic drugs were reduced or had been withdrawn
in the EMU at the discretion of the attending epileptologist.
Postictal CXRs obtained within 24 h following a GTCS were
evaluated for possible abnormality. Additionally, if available, a
baseline CXR obtained within 3 days prior to the ﬁrst GTCS and
delayed CXRs obtained within 3 days following the immediate
postictal CXR were also evaluated. CXRs initially underwent
routine clinical interpretation by board-certiﬁed radiologists at the
University of California, Davis Medical Center. Subsequently, CXRs
were also independently reviewed by one of the authors (KAH), a
board-certiﬁed pulmonologist, without knowledge of the radi-
ologist’s ﬁndings or of the clinical state of the patient. Cohen’s
kappa [16], a measure of agreement between the two sets of
interpretations for CXR ﬁndings was performed.
CXRs interpreted as showing PPE were subsequently assessed
by the pulmonologist using a clinical chest radiographic scoring
system that has been validated against direct measurements of
pulmonary edema [17]. Using this system, each lung on the
radiograph was divided into two quadrants by a horizontal line
through the center of the hilum. For each quadrant, a score
between 0 and 4 was assigned with 0 representing no edema, 1
representing edema in 0–25% of the quadrant, 2 representing
edema in 25–50% of the quadrant, 3 representing edema in 50–75%Table 1
Summary statistics.
CXR Group Mean 
Age (years) Normal 31.9 
Abnormal 32.9 
Seizure duration (s) Normal 101.2 
Abnormal 249.7 
Apnea duration (s) Normal 71.7 
Abnormal 71.6 
SpO2 nadir (%) Normal 76.0 
Abnormal 74.8 
Desaturation duration (s) Normal 82.3 
Abnormal 100.2 
ETCO2 peak (mm Hg) Normal 64.5 
Abnormal 60.20 
ETCO2 increase duration (s) Normal 310.6 
Abnormal 381.0 
Peak heart rate (beats/min) Normal 142.6 
Abnormal 142.9 
Baseline respiratory rate (breaths/min) Normal 16.4 
Abnormal 17.5 
Peak respiratory rate (breaths/min) Normal 27 
Abnormal 30 of the quadrant, and 4 representing edema in >75% of the quadrant
[17]. A total score was generated for each CXR.
The following seizure-associated variables were recorded:
interval from the end of the GTCS to acquisition of the CXR,
seizure duration, duration of ictal/postictal apnea, duration of
oxygen desaturation (SpO2 < 90%), duration of hypercapnia
(ETCO2 > 45 mm Hg), periictal SpO2 nadir, peak ETCO2, ictal peak
heart rate, baseline and peak respiratory rate and presence of any
postictal generalized EEG suppression (PGES). The study was
approved by the UC Davis Institutional Review Board.
2.1. Statistical analysis
Seizure associated variables and patient age and gender were
treated as independent variables, and the relationship of these to
CXR abnormality was determined. Logistic regression was used to
study the relationship between the presence or absence of chest
radiographic abnormalities and the independent variable in each
case. A multivariable logistic regression analysis was performed in
which the independent variables were selected based on a
stepwise selection procedure with the criterion of signiﬁcance
level (<0.2) for entering independent variables (predictors) and
signiﬁcance level (>0.25) for removing independent variables.
P-values <0.05 were considered signiﬁcant. Summary data are
presented as mean  standard deviation (median, range). All
analyses were performed with SAS v9.2 (SAS Inc., Cary, NC)
3. Results
Descriptive statistics are summarized in Table 1. There were 24
consecutive patients (19 females) admitted to the EMU who had at
least one GTCS and a CXR within 24 h of the end of the GTCS. A total
of 42 GTCS were recorded in these patients. There was close
agreement regarding CXR ﬁndings between the two reviewers. The
kappa coefﬁcient was 0.8799  0.0669 (95% CI: 0.7488–1.0)
(p < 0.0001). The blinded CXR interpretations were used for
statistical analysis.
Thirteen patients had no CXR abnormalities following 21 GTCS.
Eleven patients had at least 1 abnormal CXR following a GTCS. In
these 11 patients a total of 22 GTCS were recorded of which 14
GTCS were associated with an abnormal CXR. One GTCS was
excluded from analysis as seizure end time could not beSD Median MIN MAX p-value
13.2 29 17 58
12.1 29 19 49 0.87
42.9 88.5 50 239
180.7 216.0 74 786 0.002
27.1 70 26 120
31.7 61 30 133 0.99
7.5 75 60 91
6.9 74 66 86 0.62
55.2 66 14 183
51.4 101 12 182 0.34
16.8 58.5 44 98
21.0 57.0 38 95 0.63
325.7 140 8 826
502.1 381 26 736 0.78
17.2 146 108 174
24.8 136 108 180 0.97
3.6 15 11 22
4.7 18 10 26 0.42
7.6 25 19 50
9.6 27 19 50 0.29
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pulmonary edema score was 4.55  3.30 (4, range 2–14, IQR 2).
The mean interval from end of GTCS to CXR acquisition was
202.9  257.5 min (103, 6.2–1197). There was no signiﬁcant differ-
ence in the time to CXR following GTCS in the group of normal versus
abnormal CXRs (p = 0.312). The mean delay to CXR in the group of
normal CXRs was 196  282 min (100, 6–1197). The mean delay to
CXR after GTCS in the group with abnormal CXRs was 225  217 min
(145, 30–678). All except 1 CXR were obtained within 12 h of the end
of the seizure.
In the 11 patients with at least 1 abnormal postictal CXR, 7 CXRs
following GTCS were normal, 14 CXRs were abnormal (Fig. 1) and 1
CXR could not be classiﬁed as normal or abnormal. Seven patients
had evidence for PPE on at least 1 CXR and 4 patients had focal
inﬁltrates or atelectasis alone without PPE (Fig. 2). Two of the 7
patients with PPE also had CXR evidence for focal CXR abnormality.
Finally, 2 of the 7 patients with PPE also had CXR evidence for
cardiomegaly.
3.1. Patient characteristics
Comparing the group of patients with no CXR abnormalities
after any GTCS to the group of patients with at least 1 CXR
abnormality following a GTCS, there were no signiﬁcant differ-
ences in age (p = 0.87) or gender (p = 0.21). Details of the patients’
epilepsy and relevant comorbities are in Table 2.
3.2. Seizure characteristics
The duration of ictal/postictal apnea, duration of oxygen
desaturation, SpO2 nadir, duration of hypercapnia, peak ETCO2,
baseline and peak respiratory rate, or ictal peak heart rate were not
signiﬁcantly different in GTCS with or without CXR abnormality
(Table 1). There was no difference in CXR abnormality associated
with the presence or absence of PGES (p = 0.89).
The duration of the preceding seizure was signiﬁcantly longer
(p = 0.002) in the group of GTCS with any postictal CXR
abnormalities compared with in the group with normal CXRs.
The mean seizure duration was 249.7  181 s (216, 74–786) in the
group with CXR abnormalities and 101.2  42.9 s (88.5, 50–239) in
the group with normal CXRs (Table 1).
We then analyzed CXRs after excluding CXRs with only focal
abnormalities. In this second analysis the duration of the seizureFig. 1. Probability of CXR abnormality versus seizure duration. The large circles are
the estimated probability for CXR abnormality for a given seizure duration. The
small ﬁlled circles are the upper and lower point-wise 95% conﬁdence intervals
versus seizure duration time.remained signiﬁcantly longer (p = 0.002) in the group of GTCS with
PPE than in the group of GTCS with normal CXRs. The estimated
probability of CXR abnormality for a given seizure duration is
shown in Fig. 1. On multivariable analysis only the seizure duration
was a signiﬁcant predictor of chest CXR abnormality (p = 0.015)
when seizure duration, SpO2 nadir, desaturation duration, peak
ETCO2, peak ictal/postictal heart rate and peak respiratory rate
were included as possible predictors.
The odds-ratio for the presence of a CXR abnormality was 20.46
(95% C.L. 2.39–175.29) (p = 0.006) when seizure duration was
greater than 100 s compared with seizures less than or equal to
100 s. The odds-ratio for CXR abnormality was 171.0 comparing
seizure duration >200 s with seizures 100 s (p = 0.002).
3.2.1. Pre-GTCS and delayed post-GTCS CXRs
Five of the 11 patients with abnormal CXRs also had a CXR prior
to the ﬁrst GTCS in the EMU and all pre-GTCS CXRs were normal.
Five of these 11 patients with an abnormal GTCS-associated CXR
also had a delayed CXR within 3 days after the last GTCS. Three of
the delayed follow up CXRs were normal, one patient with marked
PPE required a diuretic and follow up CXR showed persistent but
improved PPE (Fig. 2) and one patient showed improvement in
previously present right lung opacity.
3.2.2. Seizure frequency and PPE
Four patients had PPE following the ﬁrst seizure with no other
seizures in the preceding 24 h. In the other 3 patients PPE was not
present with the ﬁrst seizure and PPE developed only when the
patient had more than one seizure in the preceding 24 h. Six
patients had more than one seizure in any 24 h period preceding a
CXR without developing PPE.
4. Discussion
In contrast to previous studies, we have shown that radio-
graphic abnormalities are often present in patients following a
GTCS and the presence of PPE is signiﬁcantly associated with the
duration of the preceding GTCS. Evidence for PPE was present in 7
of 24 patients with GTCS during admission to the EMU.
Clinical evidence for PPE, such as dyspnea, may be difﬁcult to
discern in the EMU in patients who are confused for minutes to
hours following a GTCS [18] and the main clinical focus is
assessment of the patient’s seizure. PPE when present may be
transient in most patients in the EMU, however we have seen
marked PPE requiring diuretics. PPE may not necessarily be the
direct cause of death in SUDEP and an argument can be made that
PPE is an epiphenomenon of little or no clinical relevance. However
the occurrence of PPE in about 29% of monitored patients suggests
that postictal PPE is not uncommon and may be relevant to SUDEP
pathophysiology. Focal inﬁltrates and atelectasis, contributing to
seizure-related morbidity, occurred in 6 of 24 patients following
GTCS. Aspiration pneumonia occurs in patients with seizures both
in the outpatient setting and in patients undergoing VET [19]. The
incidence of aspiration pneumonia is more common in institu-
tionalized patients and was reported to occur in 17 of 95 patients
after a generalized seizure [19]. In an epilepsy monitoring unit,
5.6% of seizures occurred while the patients were eating or
drinking, most patients received oral suctioning and only one
suspected aspiration occurred [20].
Previous animal studies support our ﬁnding that seizure-
related PPE requires prolonged convulsive seizures. In a sheep
model of generalized convulsive seizures and status epilepticus it
was shown that pulmonary microvascular pressures were elevated
in proportion to the duration of seizure stimulus [21]. Longer
duration seizures were associated with a higher rise in left atrium
and pulmonary artery pressures and pulmonary microvascular
Fig. 2. CXR in 3 patients demonstrating varying degrees of pulmonary edema. (A) 38-year-old male, 299 second right hemisphere onset seizure with secondary generalization.
CXR obtained 39 min after end of seizure. (B) 47-year-old female, 263 second left frontal seizure with secondary generalization. CXR obtained 143 min after end of seizure. (C)
54-year-old woman, 202 second right frontal seizure with secondary generalization. CXR obtained 30 min after end of seizure. The patient had 2 other GTCS in the 3 h prior
this seizure and no CXR was obtained. A routine CXR earlier that day preceding the GTCS had shown no evidence of pulmonary edema. The patient had a seizure-related
takotsubo dilated cardiomyopathy and had a cardiac pacemaker implanted. (D) Repeat CXR in patient (C) obtained the next day showing improving pulmonary edema.
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Pulmonary perfusion pressures above 30 Torr result in transca-
pillary movement of water and protein into the interstitial space
and pressures of up to 75 Torr were observed in this study with
longer seizures [21]. These high pulmonary pressures likely
damaged the capillary-alveolar membrane allowing for leakage
of RBCs and protein rich ﬂuid creating delayed PPE [22].
Although the concept of neurogenic PPE has been around over
100 years, the pathophysiology remains incompletely understood.
A neuro-hemodynamic mechanism also referred to as the ‘‘blast
theory’’ postulates a sympathetic surge with increased hydrostatic
pressure leading to alteration of Starling forces in the lungs
resulting in increased pulmonary permeability [23]. Abrupt rises in
intracranial pressure, result in intense sympathetic activation [24].
Intracranial pressure rises markedly and rapidly during generalized
convulsions in humans [25,26]. Neurological disturbances resulting
in acute increases in intracranial pressure are most likely to result in
neurogenic PPE [22,27,28]. Spinal cord transection prevents the
development of neurogenic PPE following convulsions, indicating
that the effect is neurally mediated [21]. Seizure-related transient
dilated cardiomyopathy (takotsubo cardiomyopathy) [29] resultingfrom intense sympathetic discharge [24] may also contribute to
PPE [22]. In a series of 279 consecutive patients seen in an
emergency department following seizures, 5 had takotsubo
cardiomyopathy and none of these 5 patients reported any
cardiac symptoms [30].
PPE can also result from excessive negative intrathoracic
pressure. Negative pressure PPE (NPPE) develops after deep
inspiratory effort against a closed glottis [31]. Marked and
prolonged increases in negative pressure gradients result in a
shift in ﬂuid from capillaries to lung parenchyma and eventual
damage to the capillary walls [31]. Postictal laryngospasm has
been reported [32] and NPPE may thus be relevant in some cases of
SUDEP. Severe hypoxemia may occur postictally [15,33]. Hypox-
emia causes peripheral and pulmonary vasoconstriction with
shunting of blood to pulmonary vasculature further compromising
pulmonary hemodynamics. Hypoxemia also interferes with
alveolar epithelial Na, K-ATPase active transport that is necessary
for clearance of PPE ﬂuid [34]. Disruption of the Na, K-ATPase
mechanism is an important factor in acute hypoxemic respiratory
failure [34] and likely relevant in PPE. The temporal characteristics
of this mechanism in PPE remain to be determined. A complex
Table 2
Patient and seizure characteristics.
Patient Age
(years)
Gender Seizure
onset
Seizure
frequency
Epilepsy
duration
MRI ﬁndings Co-morbidities/VNS Antiepileptic
drugs
1. 17 M BF, LF 1/2–3W 7 Y Right frontal subcortical
increased T2 signal
None LCM, LEV
2. 17 M RFT 2/M 3 Y Abnormal morphology bilateral
hippocampi. Hydrocephalus
Asthma LEV, LTG, TPM
3. 18 F LT 2/M 8 Y Left MTS None OXC, LEV
4. 58 F LT 2/W 4 Y Irregular shaped left
hippocampus
None TPM, LTG
5. 19 F RT 6–8/M 11 Y Right temporal cavernous
angioma
None OXC
6. 19 F RFT 1/M 6 Y Moderate diffuse cerebral and
cerebellar volume loss
None OXC
7. 34 F LT 3–4/M 22 Y Normal Asthma, Depression LCM, TPM
8. 21 F Gen. 20/Y 9 Y JME. No MRI Cerebral palsy LEV, LTG
9. 28 M LFT, LT 1/M 7 Y Ovoid corpus callosum splenial
lesion. No MTS
None LEV, OXC
10. 49 F LT 10/M 5 Y Left MTS Hypertension, Hypothyroidism LEV, LCM
11. 44 M RT 3/M 33 Y Normal Mild OSA (AHI = 11) LEV, LCM
12. 29 F L Hemi
R Hemi
1/W 22 Y Normal Depression, VNS LEV
13. 26 M R Hemi 1/W 20 Y Normal Depression LEV, LCM, ZNS
14. 34 F Gen. 1/2 M 21 Y Normal Depression, Transient RBBB
during convulsion, VNS
LTG, ZNS
15. 28 M LT, BF 3/W 16 Y Normal Developmental delay, VNS CBZ, LCM
16. 29 F BFC Many 8 Y Normal Developmental delay CBZ, VPA
17. 54 F RT 3/M Unknown CT head normal Polysubstance abuse, chronic
obstructive pulmonary disease,
takotsubo cardiomyopathy
LEV
18. 20 M RT 2/W 16 Y Normal Asperger syndrome ZNS, LTG
19. 33 F LT 6/W 7 Y Normal Bipolar disorder LEV
20. 49 M RT 2/Y 35 Y Bifrontal encephalomalacia None OXC, PB
21. 21 F RT 2–3/W 14 Y Normal Developmental delay None
22. 41 F LT 3/W 16 Y Left MTS Asthma LTG
23. 47 F LFC 3–4/W 5 Y Left frontal arachnoid cyst –
fenestration
Depression OXC
24. 38 M RT Daily 30 Y Right opercular cortical
dysplasia
None LEV, PHT
BF, bifrontal; LF, left frontal; BFC, bilateral frontocentral; RFT, right frontotemporal; LFT, left frontotemporal; L hemi, left hemisphere; R hemi, right hemisphere; LT, left
temporal; RT, right temporal; LFC, left frontocentral; BFC, bilateral frontocentral; Gen, generalized; W, week; M, month; Y, year; MTS, mesial temporal sclerosis; JME, juvenile
myoclonic epilepsy; VNS, vagus nerve stimulator; RBBB, right bundle branch block; OSA, obstructive sleep apnea; AHI, apnea-hypopnea index; CBZ, carbamazepine; LCM,
lacosamide; LEV, levetiracetam; LTG, lamotrigine; OXC, oxcarbazepine; PB, phenobarbital; PHT, phenytoin; TPM, topiramate; VPA, valproate; ZNS, zonisamide.
J.D. Kennedy et al. / Seizure 27 (2015) 19–24 23interaction between the various mechanisms described above may
account for the lack of a direct association between hypoxemia and
PPE observed in this study.
Routine monitoring of respiratory parameters is not performed
in most EMUs [10]. We had previously shown that there is a
persistent postictal elevation of ETCO2 above preictal values for a
mean duration in excess of 7 min despite persistent postictal
tachypnea [15]. The postictal increase in ETCO2 occurs despite an
increase in respiratory rate suggesting that the observed increase
in ETCO2 may be a consequence of pulmonary dysfunction rather
than a decrease in postictal ventilatory effort [15].
A study of CXR ﬁndings following electroconvulsive therapy
showed subclinical PPE in only one of 12 patients [14]. The mean
seizure duration in that study was 63 s. That ﬁnding lends support
to the conclusions of our present study, indicating that postictal
intrinsic pulmonary pathology is a direct function of seizure
duration. Our data were insufﬁcient to address whether the
number of GTCS in a 24-h period inﬂuenced the development of
PPE. Four of the 7 patients had PPE following the ﬁrst GTCS with no
other seizures in the preceding 24 h. On the other hand, 6 patients
had more than one GTCS in a 24 h period without developing PPE.
This suggests that perhaps the duration of a given GTCS, rather
than the frequency of brief GTCS, may be more relevant in the
development of PPE.
The high incidence of PPE found in this study may have been
inﬂuenced by rapid withdrawal of antiepileptic drugs in the EMUand the resulting prolonged generalized convulsive seizures in
some patients. The incidence of PPE may be lower in patients
having focal or partial seizures as well as shorter breakthrough
convulsions while on antiepileptic drugs.
PPE is not an infrequent occurrence in the EMU setting. Severe,
untreated postictal PPE may be relevant in the pathophysiology of
SUDEP particularly in patients with poorly controlled convulsive
seizures or following abrupt or rapid cessation of antiepileptic
drugs.
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